A new trend gaining popularity among people trying to loseweight is microdosing the diabetes medication Ozempic. With approximately 70% of American adults meeting the criteria for being obese ...
One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the weight loss drug Wegovy) were about 40 to 70 percent less likely to be ...